The DOI matches its Crossref record; 62 of the 73 references it cites were found in a registry or an index.
The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms
Open accessAbstract
Acute adverse psychological reactions to classic hallucinogens ("bad trips" or "challenging experiences"), while usually benign with proper screening, preparation, and support in controlled settings, remain a safety concern in uncontrolled settings (such as illicit use contexts). Anecdotal and case reports suggest potential adverse acute symptoms including affective (panic, depressed mood), cognitive (confusion, feelings of losing sanity), and somatic (nausea, heart palpitation) symptoms. Responses to items from several hallucinogen-sensitive questionnaires (Hallucinogen Rating Scale, the States of Consciousness Questionnaire, and the Five-Dimensional Altered States of Consciousness questionnaire) in an Internet survey of challenging experiences with the classic hallucinogen psilocybin were used to construct and validate a Challenging Experience Questionnaire. The stand-alone Challenging Experience Questionnaire was then validated in a separate sample. Seven Challenging Experience Questionnaire factors (grief, fear, death, insanity, isolation, physical distress, and paranoia) provide a phenomenological profile of challenging aspects of experiences with psilocybin. Factor scores were associated with difficulty, meaningfulness, spiritual significance, and change in well-being attributed to the challenging experiences. The factor structure did not differ based on gender or prior struggle with anxiety or depression. The Challenging Experience Questionnaire provides a basis for future investigation of predictors and outcomes of challenging experiences with classic hallucinogens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Barrett et al. (2016) created the Challenging Experience Questionnaire (CEQ), which is designed to quantify challenging experiences under the influence of psychedelics (Barrett et al., 2016).”
From Assessment of the acute subjective psychedelic experience: A review of patient-reported outcome measures in clinical research on classical psychedelics (2024) · cites this paper as Barrett et al., 2016
The cited source says what the claim attributes to it.
In the citing paper
“The CEQ comprised of 26 items, each rated on a six-point Likert scale. Seven factors are assessed, including grief, fear, death, insanity, isolation, physical distress, and paranoia, to provide a phenomenological profile of challenging aspects of experiences with a classical psychedelic.”
From Assessment of the acute subjective psychedelic experience: A review of patient-reported outcome measures in clinical research on classical psychedelics (2024) · cites this paper as Barrett et al., 2016
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hu, L., & Bentler, P. M. (1999) · Structural Equation Modeling A Multidisciplinary Journal · doi:10.1080/10705519909540118 · Cited by 108,788 · cited 11×
“Values of SRMR and RMSEA<0.1, and CFI>0.90 (Browne and Cudeck, 1993; Hu”
Influentiallavaan : An R Package for Structural Equation Modeling
Rosseel, Y. (2012) · Journal of Statistical Software · doi:10.18637/jss.v048.i02 · Cited by 27,955 · cited 2×
“Factorial invariance was assessed in a series of multiplegroup confirmatory factor models using the cfa function in the lavaan toolbox in R (Rossell, 2012), with maximum likelihood estimation.”
MethodComparative fit indexes in structural models.
Bentler, P. M. (1990) · Psychological Bulletin · doi:10.1037/0033-2909.107.2.238 · Cited by 25,266 · cited 8×
“Values of SRMR and RMSEA<0.1, and CFI>0.90 (Browne and Cudeck, 1993; Hu”
InfluentialSensitivity of Goodness of Fit Indexes to Lack of Measurement Invariance
Chen, F. F. (2007) · Structural Equation Modeling: A Multidisciplinary Journal · doi:10.1080/10705510701301834 · Cited by 12,217 · cited 3×
“change between modeling steps) indicates noninvariance (Chen, 2007).”
InfluentialGriffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., Cosimano, M. P., & Klinedinst, M. A. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675513 · Cited by 2,201 · cited 1×
“…research on psychedelics has revived their investigation as therapeutic agents (Bogenschutz et al., 2015; Carhart-Harris et al., 2012, 2016a; Griffiths et al., 2016; Grob et al., 2011; Johnson et al., 2014; Ross et al., 2016) and tools to understand psychosis (Schmid et al., 2015;…”
Self-citationNichols, D. E. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011478 · Cited by 1,762
Ross, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., Mennenga, S. E., Belser, A., Kalliontzi, K., Babb, J., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675512 · Cited by 1,698 · cited 3×
“, 2011) and anxiety secondary to a life-threatening cancer diagnosis (Griffiths et al., 2016; Ross et al., 2016), and recent large-sample surveys have demonstrated a lower risk for psychological distress and suicidality in those who have endorsed having consumed a classic hallucinogen in the past (Hendricks et al.”
Griffiths, R. R., Richards, W. A., McCann, U., & Jesse, R. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0457-5 · Cited by 1,684 · cited 16×
“…States (APZ) questionnaire) have been widely used in behavioral and neuroimaging research of pharmacologically (Gouzoulis-Mayfrank et al., 2005; Griffiths et al., 2006, 2011; Vollenweider et al., 1998) as well as non-pharmacologically induced altered states of consciousness (Hübner, 2007;…”
InfluentialSelf-citationCarhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C. M. J., Erritzoe, D., Kaelen, M., Bloomfield, M., Rickard, J. A., Forbes, B., Feilding, A., et al. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30065-7 · Cited by 1,540
Carhart-Harris, R. L., Leech, R., Hellyer, P. J., Shanahan, M., Feilding, A., Tagliazucchi, E., Chialvo, D. R., & Nutt, D. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2014.00020 · Cited by 1,252 · cited 2×
“…al, 2015; Griffiths et al., 2006, 2011) or spiritual (Kometer et al., 2015) experiences, changes in self-referential processing or “ego dissolution” (Carhart-Harris et al., 2014; Tagliazucchi et al., 2016), altered social processing (Preller et al., 2016), visual imagery (Kaelen et al., 2016),…”
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
Grob, C. S., Danforth, A. L., Chopra, G. S., Hagerty, M., McKay, C. R., Halberstadt, A. L., & Greer, G. R. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.116 · Cited by 1,206 · cited 3×
“Recent empirical work has shown the potential value of psilocybin as a treatment for depression (Carhart-Harris et al., 2016a; Grob et al., 2011) and anxiety secondary to a life-threatening cancer diagnosis (Griffiths et al.”
Human hallucinogen research: guidelines for safety
Johnson, M., Richards, W., & Griffiths, R. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108093587 · Cited by 1,203 · cited 6×
“Guidelines have been described to minimize adverse reactions in controlled settings (Johnson et al., 2008), and incidence of lasting symptoms (including psychosis) related to administration of classic hallucinogens in controlled settings is quite low (Griffiths et al., 2006, 2011; Strassman, 1984;…”
InfluentialSelf-citationPsilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
Bogenschutz, M. P., Forcehimes, A. A., Pommy, J. A., Wilcox, C. E., Barbosa, P., & Strassman, R. J. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114565144 · Cited by 1,151 · cited 1×
“The recent resurgence of empirical research on psychedelics has revived their investigation as therapeutic agents (Bogenschutz et al., 2015; Carhart-Harris et al., 2012, 2016a; Griffiths et al., 2016; Grob et al., 2011; Johnson et al., 2014; Ross et al., 2016) and tools to understand psychosis…”
BackgroundWidaman, K. F., & Reise, S. P. (1997) · The science of prevention: Methodological advances from alcohol and substance abuse research. · doi:10.1037/10222-009 · Cited by 1,146
Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action
Vollenweider, F. X., Vollenweider-Scherpenhuyzen, M. F. I., Bäbler, A., Vogel, H., & Hell, D. (1998) · NeuroReport · doi:10.1097/00001756-199812010-00024 · Cited by 1,018 · cited 1×
“…used in behavioral and neuroimaging research of pharmacologically (Gouzoulis-Mayfrank et al., 2005; Griffiths et al., 2006, 2011; Vollenweider et al., 1998) as well as non-pharmacologically induced altered states of consciousness (Hübner, 2007; Kjellgren et al., 2004; Walach and Kaseberg, 1998).”
Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects
Griffiths, R. R., Johnson, M. W., Richards, W. A., Richards, B. D., McCann, U., & Jesse, R. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2358-5 · Cited by 932 · cited 17×
“…States (APZ) questionnaire) have been widely used in behavioral and neuroimaging research of pharmacologically (Gouzoulis-Mayfrank et al., 2005; Griffiths et al., 2006, 2011; Vollenweider et al., 1998) as well as non-pharmacologically induced altered states of consciousness (Hübner, 2007;…”
InfluentialSelf-citationPilot study of the 5-HT 2A R agonist psilocybin in the treatment of tobacco addiction
Johnson, M. W., Garcia-Romeu, A., Cosimano, M. P., & Griffiths, R. R. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114548296 · Cited by 914 · cited 7×
“Approximately 30% of participants in each of three highly controlled experimental studies (total sample: 69 participants and 204 sessions – Griffiths et al., 2006, 2011; Johnson et al., 2014) involving a high dose of psilocybin (0.”
InfluentialSelf-citationGriffiths, R., Richards, W., Johnson, M., McCann, U., & Jesse, R. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108094300 · Cited by 905 · cited 1×
“…change (Carhart-Harris et al., 2016b; Lebedev et al., 2016; MacLean et al., 2011), positive mental health outcomes (Hendricks et al., 2015; Johansen and Krebs, 2015), and enduring positive changes in attitudes, mood and behavior (Griffiths et al., 2008, 2011) occasioned by these compounds.”
Self-citationMacLean, K. A., Johnson, M. W., & Griffiths, R. R. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111420188 · Cited by 895 · cited 2×
“, 2015), personality change (Carhart-Harris et al., 2016b; Lebedev et al., 2016; MacLean et al., 2011), positive mental health outcomes (Hendricks et al.”
Self-citationPsychometric evaluation of the altered states of consciousness rating scale (OAV)
Studerus, E., Gamma, A., & Vollenweider, F. X. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012412 · Cited by 683 · cited 6×
“…(Strassman, 1995; Strassman et al., 1994) and the various forms of Dittrich’s Altered States of Consciousness questionnaires (Dittrich, 1975, 1998; Studerus et al., 2010), including the Altered States of Consciousness Rating Scale (OAV) and the Five-Dimensional Altered States of Consciousness…”
InfluentialValidation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin
Barrett, F. S., Johnson, M. W., & Griffiths, R. R. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115609019 · Cited by 637 · cited 2×
“, 2016) and mystical experience (Barrett et al., 2015) are positively associated with well-being, it is not completely clear that the items of the ‘death’ subscale of the CEQ (“Profound experience of your own death” and “Feel as if dead or dying”) are collinear with either mystical experience or ego dissolution.”
Self-citationCarbonaro, T. M., Bradstreet, M. P., Barrett, F. S., MacLean, K. A., Jesse, R., Johnson, M. W., & Griffiths, R. R. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116662634 · Cited by 596 · cited 9×
“A more detailed description of the complete methods, measures, and initial findings of the online survey can be found in the original report (Carbonaro et al., 2016).”
InfluentialSelf-citationThe Standardized Psychometric Assessment of Altered States of Consciousness (ASCs) in Humans
Dittrich, A. (1998) · Pharmacopsychiatry · doi:10.1055/s-2007-979351 · Cited by 577 · cited 1×
“…Rating Scale (HRS) (Strassman, 1995; Strassman et al., 1994) and the various forms of Dittrich’s Altered States of Consciousness questionnaires (Dittrich, 1975, 1998; Studerus et al., 2010), including the Altered States of Consciousness Rating Scale (OAV) and the Five-Dimensional Altered…”
Studerus, E., Kometer, M., Hasler, F., & Vollenweider, F. X. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110382466 · Cited by 532 · cited 7×
“4%) of those participants reported prolonged symptoms (Studerus et al., 2011).”
InfluentialIncreased global functional connectivity correlates with LSD-induced ego dissolution
Tagliazucchi, E., Roseman, L., Kaelen, M., Orban, C., Muthukumaraswamy, S. D., Murphy, K., Laufs, H., Leech, R., McGonigle, J., Crossley, N., et al. (2016) · Current Biology · doi:10.1016/j.cub.2016.02.010 · Cited by 503 · cited 2×
“…2006, 2011) or spiritual (Kometer et al., 2015) experiences, changes in self-referential processing or “ego dissolution” (Carhart-Harris et al., 2014; Tagliazucchi et al., 2016), altered social processing (Preller et al., 2016), visual imagery (Kaelen et al., 2016), changes in emotional experience…”
Psilocybin-Occasioned mystical experiences in the treatment of tobacco addiction.
Garcia-Romeu, A., Griffiths, R., & Johnson, M. (2015) · Current Drug Abuse Reviews · doi:10.2174/1874473708666150107121331 · Cited by 476 · cited 1×
“Participants have also attributed positive change in well-being to their psilocybin experience, and this change in well-being has been shown to correlate positively with mystical experience (Garcia-Romeu et al., 2015) and egodissolution (Nour et al.”
Self-citationEgo-dissolution and psychedelics: validation of the ego-dissolution inventory (EDI).
Nour, M. M., Evans, L., Nutt, D., & Carhart-Harris, R. L. (2016) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2016.00269 · Cited by 470 · cited 1×
“While the experience of ego dissolution (Nour et al., 2016) and mystical experience (Barrett et al.”
Strassman, R. J. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950020022002 · Cited by 453 · cited 3×
“…used questionnaire instruments assessing the subjective effects of classic hallucinogens are the Hallucinogen Rating Scale (HRS) (Strassman, 1995; Strassman et al., 1994) and the various forms of Dittrich’s Altered States of Consciousness questionnaires (Dittrich, 1975, 1998; Studerus et al.,…”
Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects
Schmid, Y., Enzler, F., Gasser, P., Grouzmann, E., Preller, K. H., Vollenweider, F. X., Brenneisen, R., Müller, F., Borgwardt, S., & Liechti, M. E. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.11.015 · Cited by 427 · cited 2×
“, 2016) and tools to understand psychosis (Schmid et al., 2015; Vollenweider et al., 1998, 2007).”
Hendricks, P. S., Thorne, C. B., Clark, C. B., Coombs, D. W., & Johnson, M. W. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114565653 · Cited by 410 · cited 3×
“, 2016), and recent large-sample surveys have demonstrated a lower risk for psychological distress and suicidality in those who have endorsed having consumed a classic hallucinogen in the past (Hendricks et al., 2015; Johansen and Krebs, 2015).”
Self-citationPrediction of Psilocybin Response in Healthy Volunteers
Studerus, E., Gamma, A., Kometer, M., & Vollenweider, F. X. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030800 · Cited by 369 · cited 2×
“…of the importance of set (participant psychological state) and setting (interpersonal and physical environment), acute adverse effects of psychedelics may generally be minimized and successfully managed in research contexts (Johnson et al., 2008; Metzner et al., 1965; Studerus et al., 2012).”
Psychedelics not linked to mental health problems or suicidal behavior: A population study
Johansen, P.-Ø., & Krebs, T. S. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114568039 · Cited by 330 · cited 3×
“…change (Carhart-Harris et al., 2016b; Lebedev et al., 2016; MacLean et al., 2011), positive mental health outcomes (Hendricks et al., 2015; Johansen and Krebs, 2015), and enduring positive changes in attitudes, mood and behavior (Griffiths et al., 2008, 2011) occasioned by these…”
Kraehenmann, R., Preller, K. H., Scheidegger, M., Pokorny, T., Bosch, O. G., Seifritz, E., & Vollenweider, F. X. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.04.010 · Cited by 323 · cited 2×
“, 2016), changes in emotional experience (Kaelen et al., 2015; Kraehenmann et al., 2015), personality change (Carhart-Harris et al.”
Recent advances in the neuropsychopharmacology of serotonergic hallucinogens
Halberstadt, A. L. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.07.016 · Cited by 312 · cited 2×
“…acid diethylamide (LSD), mescaline, and dimethyltryptamine (DMT; contained in the sacramental beverage ayahuasca) share a primary pharmacological site of action at the serotonin 2a (5HT2a) receptor, and display striking similarities in their subjective effects (Halberstadt, 2015; Nichols, 2016).”
LSD‐induced entropic brain activity predicts subsequent personality change
Lebedev, A. V., Kaelen, M., Lövdén, M., Nilsson, J., Feilding, A., Nutt, D. J., & Carhart‐Harris, R. L. (2016) · Human Brain Mapping · doi:10.1002/hbm.23234 · Cited by 303 · cited 1×
“…et al., 2016), changes in emotional experience (Kaelen et al., 2015; Kraehenmann et al., 2015), personality change (Carhart-Harris et al., 2016b; Lebedev et al., 2016; MacLean et al., 2011), positive mental health outcomes (Hendricks et al., 2015; Johansen and Krebs, 2015), and enduring…”
Riba, J., Rodríguez-Fornells, A., Urbano, G., Morte, A., Antonijoan, R., Montero, M., Callaway, J. C., & Barbanoj, M. J. (2001) · Psychopharmacology · doi:10.1007/s002130000606 · Cited by 303 · cited 3×
“…of Consciousness Inventory (Pekala, 1986), the Minnesota Multiphasic Personality Inventory (Belleville, 1956), the States of Consciousness Questionnaire (Griffiths et al., 2006, 2011), and the Addiction Research Center Inventory (Griffiths et al., 2006, 2011; Haertzen, 1966; Riba et al., 2001).”
The paradoxical psychological effects of lysergic acid diethylamide LSD
Carhart-Harris, R. L., Kaelen, M., Bolstridge, M., Williams, T. M., Williams, L. T., Underwood, R., Feilding, A., & Nutt, D. J. (2016) · Psychological Medicine · doi:10.1017/s0033291715002901 · Cited by 293
LYSERGIC ACID DIETHYLAMIDE: SIDE EFFECTS AND COMPLICATIONS
COHEN, S. (1960) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-196001000-00005 · Cited by 287 · cited 6×
“Clinical literature and anecdotal reports indicate that paranoia is a subjective experience frequently represented in challenging experiences with classic hallucinogens (Cohen, 1960; Griffiths et al., 2006, 2011; Strassman, 1984).”
InfluentialADVERSE REACTIONS TO PSYCHEDELIC DRUGS. A REVIEW OF THE LITERATURE
Strassman, R. (1984) · Journal of Nervous and Mental Disease · doi:10.1097/00005053-198410000-00001 · Cited by 280 · cited 8×
“, 2008), and incidence of lasting symptoms (including psychosis) related to administration of classic hallucinogens in controlled settings is quite low (Griffiths et al., 2006, 2011; Strassman, 1984; Studerus et al., 2011).”
InfluentialHaertzen, C. (1966) · Psychological Reports · doi:10.2466/pr0.1966.18.1.163 · Cited by 239 · cited 1×
“…of Consciousness Inventory (Pekala, 1986), the Minnesota Multiphasic Personality Inventory (Belleville, 1956), the States of Consciousness Questionnaire (Griffiths et al., 2006, 2011), and the Addiction Research Center Inventory (Griffiths et al., 2006, 2011; Haertzen, 1966; Riba et al., 2001).”
Carhart-Harris, R. L., Leech, R., Williams, T. M., Erritzoe, D., Abbasi, N., Bargiotas, T., Hobden, P., Sharp, D. J., Evans, J., Feilding, A., et al. (2012) · British Journal of Psychiatry · doi:10.1192/bjp.bp.111.103309 · Cited by 237 · cited 1×
“The recent resurgence of empirical research on psychedelics has revived their investigation as therapeutic agents (Bogenschutz et al., 2015; Carhart-Harris et al., 2012, 2016a; Griffiths et al., 2016; Grob et al., 2011; Johnson et al., 2014; Ross et al., 2016) and tools to understand psychosis…”
Gouzoulis-Mayfrank, E., Heekeren, K., Neukirch, A., Stoll, M., Stock, C., Obradovic, M., & Kovar, K. (2005) · Pharmacopsychiatry · doi:10.1055/s-2005-916185 · Cited by 194 · cited 2×
“…(and the preceding Abnormal Mental States (APZ) questionnaire) have been widely used in behavioral and neuroimaging research of pharmacologically (Gouzoulis-Mayfrank et al., 2005; Griffiths et al., 2006, 2011; Vollenweider et al., 1998) as well as non-pharmacologically induced altered states of…”
LSD enhances the emotional response to music
Kaelen, M., Barrett, F. S., Roseman, L., Lorenz, R., Family, N., Bolstridge, M., Curran, H. V., Feilding, A., Nutt, D., & Carhart-Harris, R. L. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4014-y · Cited by 179 · cited 1×
“…Tagliazucchi et al., 2016), altered social processing (Preller et al., 2016), visual imagery (Kaelen et al., 2016), changes in emotional experience (Kaelen et al., 2015; Kraehenmann et al., 2015), personality change (Carhart-Harris et al., 2016b; Lebedev et al., 2016; MacLean et al., 2011),…”
Self-citationFreeman, D. H., Dunn, G., Murray, R. M., Evans, N., Lister, R., Antley, A., Slater, M., Godlewska, B. R., Cornish, R., Williams, J. H., et al. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu098 · Cited by 170 · cited 1×
“An accepted clinical definition of “paranoia” is “unfounded fears that others intend harm to the individual” (Freeman et al., 2015).”
Effects of serotonin 2A/1A receptor stimulation on social exclusion processing
Preller, K. H., Pokorny, T., Hock, A., Kraehenmann, R., Stämpfli, P., Seifritz, E., Scheidegger, M., & Vollenweider, F. X. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1524187113 · Cited by 169 · cited 2×
“, 2016), altered social processing (Preller et al., 2016), visual imagery (Kaelen et al.”
Kometer, M., Pokorny, T., Seifritz, E., & Volleinweider, F. X. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4026-7 · Cited by 169 · cited 2×
“, 2006, 2011) or spiritual (Kometer et al., 2015) experiences, changes in self-referential processing or “ego dissolution” (Carhart-Harris et al.”
Vollenweider, F., Csomor, P., Knappe, B., Geyer, M., & Quednow, B. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301324 · Cited by 159 · cited 1×
“…has revived their investigation as therapeutic agents (Bogenschutz et al., 2015; Carhart-Harris et al., 2012, 2016a; Griffiths et al., 2016; Grob et al., 2011; Johnson et al., 2014; Ross et al., 2016) and tools to understand psychosis (Schmid et al., 2015; Vollenweider et al., 1998, 2007).”
LSD modulates music-induced imagery via changes in parahippocampal connectivity
Kaelen, M., Roseman, L., Kahan, J., Santos-Ribeiro, A., Orbán, C., Lorenz, R., Barrett, F. S., Bolstridge, M., Williams, T., Williams, L., et al. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.03.018 · Cited by 135 · cited 1×
“…or “ego dissolution” (Carhart-Harris et al., 2014; Tagliazucchi et al., 2016), altered social processing (Preller et al., 2016), visual imagery (Kaelen et al., 2016), changes in emotional experience (Kaelen et al., 2015; Kraehenmann et al., 2015), personality change (Carhart-Harris et al.,…”
Self-citationMeasurement of Phenomenological Experience: Phenomenology of Consciousness Inventory
Pekala, R. J., Steinberg, J., & Kumar, V. K. (1986) · Perceptual and Motor Skills · doi:10.2466/pms.1986.63.2.983 · Cited by 106 · cited 3×
“Many other instruments were either used or developed to assess various aspects of subjective experience of hallucinogens, including the Linton-Langs questionnaire (Linton and Langs, 1962), the Abramson questionnaire (Abramson, 1960), the Phenomenology of Consciousness Inventory (Pekala, 1986), the Minnesota Multiphasi…”
The Peak Experience Variable in DPT-Assisted Psychotherapy with Cancer Patients
Richards, W. A., Rhead, J., Dileo, F., Yensen, R., & Kurland, A. (1977) · Journal of Psychedelic Drugs · doi:10.1080/02791072.1977.10472020 · Cited by 97 · cited 2×
“No items from the MEQ43 were included in the present analysis.”
Hallucinogenic Drugs in Psychiatric Research and Treatment Perspectives and Prospects
Strassman, R. (1995) · Journal of Nervous and Mental Disease · doi:10.1097/00005053-199503000-00002 · Cited by 96 · cited 2×
“…two most widely used questionnaire instruments assessing the subjective effects of classic hallucinogens are the Hallucinogen Rating Scale (HRS) (Strassman, 1995; Strassman et al., 1994) and the various forms of Dittrich’s Altered States of Consciousness questionnaires (Dittrich, 1975, 1998;…”
LSD before Leary: Sidney Cohen's Critique of 1950s Psychedelic Drug Research
Novak, S. (1997) · Isis · doi:10.1086/383628 · Cited by 71 · cited 1×
“…exceedingly rare ( 0.001% of healthy individuals, and 0.002% of individuals undergoing therapy), however this summary must be viewed tentatively, given numerous limitations including, for example, that none of the reporting investigators had conducted follow-up with their patients (Novak, 1997).”
InfluentialManagement of "bad trips" in an evolving drug scene.
Taylor, R. L., Maurer, J., & Tinklenberg, J. (1970) · Journal of the American Medical Association (JAMA) · doi:10.1001/jama.1970.03170290018003 · Cited by 58 · cited 1×
“However, the review noted that emergency department reports (e.g. McCabe, 1977; Taylor et al., 1970) are limited by uncertainty of substance ingested and unknown mental state of the patient prior to putative ingestion of a psychoactive substance.”
Ungerleider, J., Fisher, D. D., & Fuller, M. (1966) · Journal of the American Medical Association (JAMA) · doi:10.1001/jama.1966.03110060063015 · Cited by 52
Kjellgren, A., Sundequist, U., Sundholm, U., Norlander, T., & Archer, T. (2004) · Social Behavior and Personality An International Journal · doi:10.2224/sbp.2004.32.2.103 · Cited by 46 · cited 2×
“…used in behavioral and neuroimaging research of pharmacologically (Gouzoulis-Mayfrank et al., 2005; Griffiths et al., 2006, 2011; Vollenweider et al., 1998) as well as non-pharmacologically induced altered states of consciousness (Hübner, 2007; Kjellgren et al., 2004; Walach and Kaseberg, 1998).”
A guide to multiple-sample structural equation modeling
Lomax, R. (1983) · Behavior Research Methods · doi:10.3758/bf03203726 · Cited by 46 · cited 1×
“…performing a series of multiple-group confirmatory factor analyses, adding more constraints in each sequential model for parameters to be equal across groups and then testing to see whether model fit improves or degrades across sequential models (Kline, 2005; Lomax, 1983; Widaman and Reise, 1997).”
The "bad trip"--the etiology of the adverse LSD reaction.
Ungerleider, J., Fisher, D. D., Fuller, M., & Caldwell, A. (1968) · American Journal of Psychiatry · doi:10.1176/ajp.124.11.1483 · Cited by 45
Placebo reactions in a study of lysergic acid diethylamide (LSD-25).
Linton, H. B., & Langs, R. (1962) · Archives of General Psychiatry · doi:10.1001/archpsyc.1962.01710230037004 · Cited by 28 · cited 2×
“…were either used or developed to assess various aspects of subjective experience of hallucinogens, including the Linton-Langs questionnaire (Linton and Langs, 1962), the Abramson questionnaire (Abramson, 1960), the Phenomenology of Consciousness Inventory (Pekala, 1986), the Minnesota…”
MMPI score changes induced by lysergic acid diethylamide (LSD-25).
Belleville, R. E. (1956) · Journal of Clinical Psychology · doi:10.1002/1097-4679(195607)12:3 · Cited by 18
Psychedelic Drug Crises: Toxicity and Therapeutics
McCabe, O. (1977) · Journal of Psychedelic Drugs · doi:10.1080/02791072.1977.10472036 · Cited by 16 · cited 4×
“Additional categories of challenging experience have been suggested in the literature, such as the experience of karmic or “astral” experiences, experience of “kundalini” energy, or the experience of such phenomena as age regression (McCabe, 1977).”
InfluentialWalach, H., & Käseberg, E. (1998) · Behavioral Medicine · doi:10.1080/08964289809596388 · Cited by 13 · cited 2×
“…used in behavioral and neuroimaging research of pharmacologically (Gouzoulis-Mayfrank et al., 2005; Griffiths et al., 2006, 2011; Vollenweider et al., 1998) as well as non-pharmacologically induced altered states of consciousness (Hübner, 2007; Kjellgren et al., 2004; Walach and Kaseberg, 1998).”
Abramson, H. (1960) · Journal of Mental Science · doi:10.1192/bjp.106.444.1120 · Cited by 7 · cited 2×
“…aspects of subjective experience of hallucinogens, including the Linton-Langs questionnaire (Linton and Langs, 1962), the Abramson questionnaire (Abramson, 1960), the Phenomenology of Consciousness Inventory (Pekala, 1986), the Minnesota Multiphasic Personality Inventory (Belleville, 1956), the…”
Research works printed but not linked: 12
- Browne MW, 1993, Testing Structural Equation Models, 136
- Dittrich A, 1975, Z Klin Psychol Psychiatr Psychother, 23, 12
- Dittrich A, 2010, 5D-ASC: Questionnaire for the Assessment Of Altered States of Consciousness. A Short Introduction
- Freeman D, 2015, SchizophrBull, 41, 391
- Frecska E, 2006, Neuropsychopharmacol Hung, 8, 189
- Hübner C, 2007, Music Therapy Today, 8, 257
- Kline RB, 2005, Principles and Practice of Structural Equation Modeling
- Metzner R, 1965, Psychedelic Review, 5, 3
- Pahnke WN, 1969, Curr Psychiatr Ther, 9, 144
- 10.1093/oso/9780195096736.001.0001 · DOI · Paper page
- R Core Team, 2012, R: A Language and Environment for Statistical Computing
- Rossell Y, 2012, J Stat Softw, 48, 1
Cited by
Sorted by citations
Roseman, L., Nutt, D. J., & Carhart-Harris, R. L. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00974 · Cited by 808
“Recent work has sought to develop and validate a measure that is sensitive to difficult or challenging psychedelic experiences (Barrett et al., 2016; Carbonaro et al., 2016) and there is some evidence that the intensity of such experiences is predictive of positive long-term outcomes, whereas the duration of struggle…”
BackgroundSerotonin and brain function: a tale of two receptors
Carhart-Harris, R., & Nutt, D. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117725915 · Cited by 739
“, 2006) (although acute panic can occur (Barrett et al., 2016; Carbonaro et al., 2016)), yet there is increasing evidence that anxiety can be significantly reduced for a prolonged period after a therapeutically mediated psychedelic drug experience (Gasser et al.”
BackgroundPsychedelics and the essential importance of context
Carhart-Harris, R. L., Roseman, L., Haijen, E., Erritzoe, D., Watts, R., Branchi, I., & Kaelen, M. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881118754710 · Cited by 657
“More specifically, whereas we saw a trend relationship between challenging experience under a psychedelic and less of an increase in psychological well-being 2 weeks later, others have found evidence that challenging experiences can be therapeutically beneficial (Barrett et al., 2016; Carbonaro et al., 2016).”
BackgroundPredicting responses to psychedelics: a prospective study
Haijen, E. C. H. M., Kaelen, M., Roseman, L., Timmermann, C., Kettner, H., Russ, S., Nutt, D., Daws, R. E., Hampshire, A. D. G., Lorenz, R., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00897 · Cited by 417
“The Challenging Experience Questionnaire (CEQ) (Barrett et al., 2016) contains 30 items leading to a total score and seven subscales scores (i.”
BackgroundEmotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory
Roseman, L., Haijen, E., Idialu-Ikato, K., Kaelen, M., Watts, R., & Carhart-Harris, R. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119855974 · Cited by 413
“Email: leor.roseman13@imperial.ac.uk outcomes, thus suggesting that CE might be counter-therapeutic and perhaps even iatrogenic (Barrett et al., 2016; Carbonaro et al., 2016; Haijen et al., 2018; Roseman et al., 2017), although there are some contradictory findings in this regard, suggesting a more…”
BackgroundResultInfluential
Metadata
- Authors
- Barrett, F. S., Bradstreet, M. P., Leoutsakos, J.-M. S., Johnson, M. W., & Griffiths, R. R.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Barrett, Frederick S
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2016-11-19
- Volume
- 30
- Issue
- 12
- Pages
- 1279-1295
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- PMC
- PMC5549781
- OpenAlex
- W2549202270
- Cited by
- 366
- References
- 73
- Citations by year
- 2026: 43 · 2025: 77 · 2024: 93 · 2023: 41 · 2022: 39 · 2021: 32 · 2020: 15 · 2019: 10 · 2018: 13 · 2017: 3
- FWCI
- 11.60
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Drug Abuse (R01DA003889, T32DA007209)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Social Sciences › Psychology › Social Psychology › Paranormal Experiences and Beliefs
- Social Sciences › Health › Religion, Spirituality, and Psychology
- Keywords
- psilocybin, challenging experiences, bad trips, questionnaire validation, grief, fear, death, paranoia, isolation, physical distress, altered states of consciousness, meaningfulness, spiritual meaning, well-being
- MeSH terms
- Adult, Affect, Agaricales, Anxiety, Depression, Emotions, Female, Hallucinogens, Humans, Male, Psilocybin, Surveys and Questionnaires
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review